Infectious diseases and vaccines Archives - Page 7 of 11

The impact of a new antimicrobial stewardship tool, “ICNet Pharmacy”, at Chelsea and Westminster Hospital NHS Foundation Trust

Authors: Stephen Hughes, Orla Geoghegan Published: 2017 View publication Overview In April 2016 Chelsea and Westminster Hospital NHS Foundation Trust (C&W) implemented ICNet Pharmacy (ICNet), an antimicrobial stewardship (AMS) software which runs...

Real world impact of rifaximin-α use in hepatic encephalopathy patients with advanced liver disease or continued alcohol misuse: A post-hoc analysis of the IMPRESS study

Authors: M Hudson, P Di Maggio, R Cipelli, R Aspinall Published: United European Gastroenterology Journal, 2017 View publication

Prevalence of transmitted resistance to nonnucleoside reverse transcriptase inhibitors in european and north american countries over 20 years: an updated meta-analysis

Authors: SJ Snedecor Published: AIDS Research and Human Retroviruses, 2021 View publication Abstract The prevalence of transmitted nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance around the world have been estimated up to 2010....

Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis

Authors: K Nickel, N J A Halfpenny, S J Snedecor, Y S Punekar Published: BMC Infectious Diseases, 2021 View publication Background The objective of this study was to assess the durability of...

Potential public health impact of a neisseria meningitidis A, B, C, W, and Y pentavalent vaccine in the United States

Authors: L Huang, S J Snedecor, P Balmer, A Srivastava Published: Postgraduate medicine, 2021 View publication Objective Globally, 5 serogroups (A, B, C, W, and Y) cause the majority of invasive meningococcal...

Budget impact analysis of introducing a non-reconstituted, hexavalent vaccine for pediatric immunization in the United Kingdom

Authors: D A R Mathijssen, M Heisen, J F Clark-Wright, L J Wolfson, X Lu, S Carrol, B C P van Dijk, S L Klijn, B Alemayehu Published: Expert review of vaccines,...

Cost-utility of all-oral direct-acting antiviral regimens for the treatment of genotype 1 chronic hepatitis C virus-infected patients in Hong Kong

Authors: M F Yuen, S H Liu, W K Seto, L Y Mak, S L Corman, D C Hsu, M Y K Lee, T K Khan, A Puenpatom Published: Digestive Diseases and...

Early switch/early discharge opportunities for hospitalized patients with methicillin resistant staphylococcus aureus complicated skin and soft tissue infections: Saudi Arabia and United Arab Emirates

Authors: A El Houfi, A A l Thaqafi, T H Alenazi, F Farahat, C T Solem, J M Stephens, C Johnson, C Macahilig, W Y Tang, S Haider Published: Journal of Infection...

Oral corticosteroid exposure and increased risk of related complications in patients with noninfectious intermediate, posterior, or panuveitis: real-world data analysis

Authors: V V Chirikov, R Shah, Y Kwon, D Patel Published: Ophthalmic Epidemiology, 2019 View publication Purpose This study causally examined the dose-response relationship between oral corticosteroids (OCS) exposure and long-term complications...

News